Cargando…
HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway
Hepatocellular carcinoma (HCC) is one of the most common human cancers, its prevalence and severity need us to discover novel early diagnostic biomarkers and new therapeutic strategies. MicroRNA-122 is the most abundant microRNA in the liver, and acts as a tumor suppressor and represses HCC developm...
Autores principales: | Yang, Guang, Zhang, Min, Zhao, Yawei, Pan, Yue, Kan, Mujie, Li, Jing, He, Kan, Zhang, Xuewen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094838/ https://www.ncbi.nlm.nih.gov/pubmed/32210451 http://dx.doi.org/10.1371/journal.pone.0230450 |
Ejemplares similares
-
Retraction: HNF-4α inhibits hepatocellular carcinoma cell proliferation through mir-122-adam17 pathway
Publicado: (2023) -
Association of MiRNA122 & ADAM17 with Lipids among Hypertensives in Nigeria
por: Meka, Ijeoma A., et al.
Publicado: (2018) -
Loss of HNF1α Function Contributes to Hepatocyte Proliferation and Abnormal Cholesterol Metabolism via Downregulating miR-122: A Novel Mechanism of MODY3
por: Hu, Mengdie, et al.
Publicado: (2020) -
Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17
por: Yang, Guang, et al.
Publicado: (2021) -
Gα(12) overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction
por: Yang, Yoon Mee, et al.
Publicado: (2015)